US Patent Issued to NURITAS on Aug. 26 for "Treatment of non-alcoholic fatty liver disease" (Irish Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,180, issued on Aug. 26, was assigned to NURITAS Ltd. (Dublin).

"Treatment of non-alcoholic fatty liver disease" was invented by Nora Khaldi (Dublin), Alessandro Adelfio (Dublin) and Cyril Lopez (Dublin).

According to the abstract* released by the U.S. Patent & Trademark Office: "The Applicant has discovered that the peptide of SEQUENCE ID NO: 1 (WKDEAGKPLVK) mediates changes in key biomarker activities associated with NASH (Table 1), and that the peptide is capable of penetrating HepG2 liver cells in a hepatic cell penetration assay (FIG. 1). In addition, the Applicant demonstrates that treatment with pep_260 (SEQ ID 1) for 44 days significantly relieves macro-vesicular steatosis...